Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration

Journal of Visualized Experiments

Volumn , Issue 60, 2012, Pages

  Renda, Anthony ^a   Nashmi, Raad ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Issue 60; Knock in mice; Neuroscience; Nicotine addiction; Nicotinic acetylcholine receptors; Spectral confocal imaging; Yellow fluorescent protein

Indexed keywords

EID: 84857880091     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3516     Document Type: Article

References (31)

1. Perry, D.C., Davila-Garcia, M.I., Stockmeier, C.A., & Kellar, K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289, 1545-52 (1999).
2. Schwartz, R.D. & Kellar, K.J. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science. 220, 214-6 (1983).
3. Marks, M.J., Burch, J.B., & Collins, A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817-25 (1983).
4. Carlezon, W.A.J. & Nestler, E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci. 25, 610-5 (2002).
5. Fitzgerald, L.W., Ortiz, J., Hamedani, A.G., & Nestler, E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16, 274-82 (1996).
6. Saal, D., Dong, Y., Bonci, A., & Malenka, R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 37, 577-82 (2003).
7. Tsien, R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67, 509-44 (1998).
8. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., & Prasher, D.C. Green fluorescent protein as a marker for gene expression. Science. 263, 802-5 (1994).
9. Feng, G., Mellor, R.H., Bernstein, M., Keller-Peck, C., Nguyen, Q.T., Wallace, M., et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 28, 41-51 (2000).
10. Livet, J., Weissman, T.A., Kang, H., Draft, R.W., Lu, J., Bennis, R.A., et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature. 450, 56-62 (2007).
11. Nashmi, R., Dickinson, M.E., McKinney, S., Jareb, M., Labarca, C., Fraser, S.E., et al. Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J. Neurosci. 23, 11554-67 (2003).
12. Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S.R., Whiteaker, P., et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J. Neurosci. 27, 8202-18 (2007).
13. Dickinson, M.E., Bearman, G., Tilie, S., Lansford, R., & Fraser, S.E. Multi-spectral imaging and linear unmixing add a whole new dimension to laser scanning fluorescence microscopy. BioTechniques. 31, 1272-1278 (2001).
14. Nashmi, R., Fraser, S.E., Lester, H., & Dickinson, M.E. In Molecular imaging: fret microscopy and spectroscopy. Periasamy, A. & Day, R.N., eds., 180-192, Oxford University Press, (2005).
15. Zimmermann, T., Rietdorf, J., Girod, A., Georget, V., & Pepperkok, R. Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair. FEBS Lett. 531, 245-9 (2002).
16. Larson, J.M. The Nikon C1si combines high spectral resolution, high sensitivity, and high acquisition speed. Cytometry A. 69, 825-34 (2006).
17. Melvin, N.R. & Sutherland, R.J. Quantitative caveats of standard immunohistochemical procedures: implications for optical disector-based designs. J. Histochem. Cytochem. 58, 577-84 (2010).
18. Jones, I.W. & Wonnacott, S. Why doesn't nicotinic ACh receptor immunoreactivity knock out? Trends Neurosci. 28, 343-5 (2005).
19. Moser, N., Mechawar, N., Jones, I., Gochberg-Sarver, A., Orr-Urtreger, A., Plomann, M., et al. Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J. Neurochem., (2007).
20. Whiteaker, P., Cooper, J.F., Salminen, O., Marks, M.J., McClure-Begley, T.D., Brown, R.W., Collins, A.C., & Lindstrom, J.M. Immunolabeling demonstrates the interdependence of mouse brain a4 and b2 nicotinic acetylcholine receptor subunit expression. The Journal of Comparative Neurology. 499, 1016-38 (2006).
21. Marks, M.J., McClure-Begley, T.D., Whiteaker, P., Salminen, O., Brown, R.W.B., Cooper, J., Collins, A.C., & Lindstrom, J.M. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 337, 187-200 (2011).
22. Marks, M.J., Rowell, P.P., Cao, J.Z., Grady, S.R., McCallum, S.E., & Collins, A.C. Subsets of acetylcholine-stimulated 86[Rb]+ efflux and 125[I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology. 46, 1141-57 (2004).
23. King, S.L., Caldarone, B.J., & Picciotto, M.R. Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology. 47 Suppl. 1, 132-9 (2004).
24. Robinson, S.F., Marks, M.J., & Collins, A.C. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl.) 124, 332-9 (1996).
25. Sparks, J.A. & Pauly, J.R. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl.) 141, 145-53 (1999).
26. Rahman, S., Zhang, J., Engleman, E.A., & Corrigall, W.A. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study. Neuroscience. 129, 415-24 (2004).
27. Picciotto, M.R., Zoli, M., Rimondini, R., Lena, C., Marubio, L.M., Pich, E.M., et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature. 391, 173-177 (1998).
28. Fowler, C.D., Lu, Q., Johnson, P.M., Marks, M.J., & Kenny, P.J. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature. 471, 597-601 (2011).
29. Maskos, U., Molles, B.E., Pons, S., Besson, M., Guiard, B.P., Guilloux, J.P., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 436, 103-7 (2005).
30. Matta, S.G., Balfour, D.J., Benowitz, N.L., Boyd, R.T., Buccafusco, J.J., Caggiula, A.R., Craig, C.R., Collins, A.C., Damaj, M.I., Donny, E.C., Gardiner, P.S., Grady, S.R., Heberlein, U., Leonard, S.S., Levin, E.D., Lukas, R.J., Markou, A., Marks, M.J., McCallum, S.E., Parameswaran, N., Perkins, K.A., Picciotto, M.R., Quik, M., Rose, J.E., Rothenfluh, A., Schafer, W.R., Stolerman, I.P., Tyndale, R.F., Wehner, J.M., & Zirger, J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190, 269-319 (2007).
31. Lang, T. & Rizzoli, S.O. Membrane protein clusters at nanoscale resolution: more than pretty pictures. Physiology (Bethesda). 25, 116-24 (2010).